Drug Design Engine
Unified AI system, built on and beyond AlphaFold, that models drug candidates across small molecules and biologics for historically difficult targets. Used internally and through pharma co-development partnerships (e.g. Eli Lilly, Novartis) rather than sold directly.
Find alternatives to Drug Design Engine
Not sold as a product — used internally and licensed only through pharma co-development partnerships. The official site names no purchase or contact-sales path, only partnership inquiries, so no charging model could be established.
What it does
- Drug discovery
How it compares
-
Chai Discovery platform
Isomorphic Labs was founded in 2021 as a DeepMind spinout led by Demis Hassabis.
Research report · 19 Sep 2026 -
Recursion OS
Both are AI-native drug-discovery platforms — Recursion OS against Isomorphic's Drug Design Engine — named as rivals in Recursion's own 10-K.
Representative examples include Relay Therapeutics, Isomorphic Labs, Schrodinger, and AbCellera.
Regulatory filing · 25 Feb 2026
Sources
- Sold within
-
The page describes "Isomorphic Labs’ unified drug design engine" and says "In addition to our partnered programs, we are also developing an internal drug candidate pipeline focused in oncology and immunology." It names no purchase, licence or signup route for the engine.
Open Isomorphic Labs in the directory
Something wrong here? Send a correction — quote this product id: isomorphic-labs-drug-design-engine.